Compare Duolingo Inc (DUOL) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Duolingo Inc vs Oscar Health Inc — how do they compare? Duolingo Inc trades at $149.92 (market cap $7.08B), while Oscar Health Inc trades at $33.37 (market cap $10.22B). The key difference: Oscar Health Inc is the larger of the two by market cap, and Oscar Health Inc is trading nearer its 52-week high, Duolingo Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Duolingo Inc for 137 Days and Oscar Health Inc for 15 Days on average.
| DUOL | OSCR | |
|---|---|---|
Market Cap | $7.08B | $10.22B |
Volume | 729,171 | 4,123,394 |
Sector | Technology | Health |
52-Week High | $341.08 | $33.81 |
52-Week Low | $90.03 | $10.85 |
Typical Hold Time | 137 Days | 15 Days |
Enterprise Value | $5.85B | $6.57B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Duolingo (DUOL) trades at $151.22, down 0.33% on the day, with strong technical momentum indicated by bullish moving averages. The company demonstrates robust fundamentals with 2025 revenue reaching $1.04 billion and net income of $414.07 million, representing a 35.87% net margin. Recent earnings have consistently beaten expectations, with Q2 2026 EPS of $0.66 surpassing the $0.604 estimate. Technical analysis shows support at $150 and resistance at $152, with the stock trading near recent highs.
Duolingo presents a compelling growth story with strong profitability metrics and consistent earnings beats, though valuation multiples remain elevated. Key risks include insider selling activity and competitive pressures in the edtech space. Analyst consensus leans cautious with 54% hold ratings, but the company's AI-driven content creation and user growth strategy provides long-term upside potential if monetization improves.
OSCR trades at $33.1, up 0.58% on the day, with a bullish technical signal from moving averages. The company reported strong Q1 and Q2 2026 earnings beats, with revenue growth from $11.7B in 2025 to a projected $15.3B in 2026, turning to a net profit. Analyst consensus is a $34 price target, with 31% buy ratings. Recent news highlights market share gains and raised 2026 guidance following its Investor Day.
The outlook is positive, driven by execution in the ACA market and new growth avenues, but risks include rising medical costs threatening profitability and a high P/E ratio. The stock offers growth potential if margin expansion continues as guided.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Duolingo Inc
Duolingo Inc is a mobile learning platform to learn languages and the top-grossing app in the Education category on both Google Play and the Apple App Store. It has three predominant sources of revenue
Read more on DUOL →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
